We hypothesized that LAP2 protein expression could be differentially modulated in the hearts of males vs. females, which could increase the occurrence and/or the severity of the cardiomyopathies associated with TMPO/LAP2α variants specifically in males. Here, TMPO is linked to cardiomyopathy.